A Phase 2, Double-blind, Randomized, Placebocontrolled Study to Evaluate the Effects of Sotatercept
versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension
(Cpc-PH) due to Heart Failure with Preserved Ejection Fraction (HFpEF)
A Phase 2 Study of Sotatercept for Cpc-PH Treatment
Please use this link for further information:
Primary Investigator: Peter Engel, MD